Putnam Investments’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-86,979
| Closed | -$10.5M | – | 1233 |
|
|
2023
Q1 | $10.5M | Sell |
86,979
-1,361
| -2% | -$164K | 0.02% | 302 |
|
|
2022
Q4 | $10.1M | Buy |
88,340
+13,464
| +18% | +$1.55M | 0.02% | 279 |
|
|
2022
Q3 | $7.66M | Sell |
74,876
-8,530
| -10% | -$873K | 0.01% | 339 |
|
|
2022
Q2 | $8.47M | Buy |
83,406
+11,325
| +16% | +$1.15M | 0.02% | 330 |
|
|
2022
Q1 | $8.39M | Buy |
72,081
+1,030
| +1% | +$120K | 0.01% | 380 |
|
|
2021
Q4 | $8.08M | Buy |
+71,051
| New | +$8.08M | 0.01% | 425 |
|
|
2021
Q1 | – | Sell |
-55,818
| Closed | -$6.1M | – | 857 |
|
|
2020
Q4 | $6.1M | Sell |
55,818
-22,003
| -28% | -$2.4M | 0.01% | 467 |
|
|
2020
Q3 | $8.66M | Buy |
77,821
+11,845
| +18% | +$1.32M | 0.02% | 362 |
|
|
2020
Q2 | $6.92M | Buy |
+65,976
| New | +$6.92M | 0.01% | 406 |
|